Inventor · disambiguated record
William M. Pandak
Also filed as: PANDAK WILLIAM M
5 granted patents·2 pending applications·33 citations·filing 2002–2020
78Inventor score
Top patents by PatentIndex Score
7 records- 0190US10144759B2Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisUNIV VIRGINIA COMMONWEALTH·Filed 2016·Granted Dec 4, 2018·4 cites·15 claims
- 0289US8399441B2Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisREN SHUNLIN·Filed 2010·Granted Mar 19, 2013·21 cites·5 claims
- 0384US11384115B2Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisUNIV VIRGINIA COMMONWEALTH·Filed 2020·Granted Jul 12, 2022·1 cites·20 claims
- 0484US10844089B2Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisUNIV VIRGINIA COMMONWEALTH·Filed 2018·Granted Nov 24, 2020·1 cites·6 claims
- 0582US9321802B2Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosisUNIV VIRGINIA COMMONWEALTH·Filed 2013·Granted Apr 26, 2016·6 cites·2 claims
- 0667US2007275939A1Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosisREN SHUNLIN·Filed 2007·Application pending·0 cites
- 0739US2003092092A1Antitryptase autoantibody-tryptase immune complex as a unique marker for diagnosis and as a potential target for therapy of immediate hypersensitivity diseasesPAX BIOGEN CO LTD·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William M. Pandak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →